INOZYME PHARMA INC. -
5.2100
07-October-24 15:59:31
15 minutes delayed
Stocks
+0.0400
+0.77%
Today's range
5.1200 - 5.2800
ISIN
N/A
Source
NASDAQ
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 May 2023 08:30:00 By Nasdaq GlobeNewswire
-
14 Apr 2023 08:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate at the 22nd Annual Needham Virtual Healthcare Conference
11 Apr 2023 08:30:00 By Nasdaq GlobeNewswire
-
04 Apr 2023 08:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Full Year 2022 Financial Results and Provides Business Highlights
22 Mar 2023 08:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate in the Cowen 43rd Annual Health Care Conference
01 Mar 2023 08:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701
16 Feb 2023 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma to Host Virtual Investor and Analyst Event on Feb. 16, 2023
06 Feb 2023 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma Announces Investor and Analyst Event and Highlights 2022 Progress
09 Jan 2023 08:30:00 By Nasdaq GlobeNewswire
-
05 Dec 2022 08:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate at the BofA Securities Biotech SMID Cap Conference
01 Dec 2022 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Third Quarter 2022 Financial Results and Provides Business Updates
10 Nov 2022 08:30:01 By Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate in Upcoming Investor Conferences
07 Nov 2022 07:30:00 By Nasdaq GlobeNewswire
-
03 Nov 2022 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma Announces Publication of Comprehensive ENPP1 Variant Database
31 Oct 2022 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma to Present at H.C. Wainwright 24th Annual Global Investment Conference
06 Sep 2022 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Second Quarter 2022 Financial Results and Provides Business Updates
15 Aug 2022 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma Secures Flexible Debt Facility for up to $70 Million with K2 HealthVentures
26 Jul 2022 07:30:00 By Nasdaq GlobeNewswire
-
19 Jul 2022 16:30:00 By Nasdaq GlobeNewswire
-
16 Jun 2022 07:30:00 By Nasdaq GlobeNewswire